Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
Assessment of time to clinical response, a proxy for discharge readiness, among hospitalized patients with community-acquired pneumonia who received either ceftaroline fosamil or ceftriaxone in two phase III FOCUS trials. MedStar authors:
Year: 2015
Citation: - Antimicrobial Agents & Chemotherapy. 59(2):1119-26, 2015 Feb.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Anzueto AR, File TM, Huang X, Lodise TP, Shorr AF, Smith A, Weber DJ, Yang M, Zhao Q
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials. MedStar authors:
Year: 2019
Citation: - Clinical Infectious Diseases. 69(11):1912-1918, 2019 11 13.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
All authors: - Alder J, Asehnoune K, Bassetti M, Bonten MJM, Chastre J, De Waele J, Dimopoulos G, Eggimann P, Engelhardt M, Ewig S, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer LB, Papazian L, Poulakou G, Prokocimer P, Rello J, Rex JH, Shorr AF, Talbot GH, Thamlikitkul V, Timsit JF, Torres A, Weiss E, Wunderink RG, Zahar JR
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. MedStar authors:
Year: 2021
Citation: - The Lancet Infectious Diseases. 21(2):213-225, 2021 02.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
All authors: - Ariyasu M, Clevenbergh P, Echols R, Kaye KS, Kollef M, Matsunaga Y, Menon A, Nagata TD, Pogue JM, Shorr AF, Timsit JF, Wunderink RG, Zeitlinger M
|
|
|
18.
|
|
|
|
19.
|
|
|
|
20.
|
|
|
|
21.
|
|
|
|
22.
|
|
|
|
23.
|
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. MedStar authors:
Year: 2012
Citation: - Clinical Infectious Diseases. 54(5):621-9, 2012 Mar 1.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
- Clinical Trial, Phase IV
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baruch A, Chastre J, Kollef MH, Kunkel MJ, McGee WT, Niederman MS, Reisman A, Shorr AF, Wunderink RG
|
|
|
24.
|
|
|
|
25.
|
|
|
|
26.
|
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality. MedStar authors:
Year: 2015
Citation: - Clinical Infectious Diseases. 61 Suppl 2:S87-93, 2015 Sep 15.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Barriere SL, Corey GR, Hardin TC, Lacy MK, Luke DR, Nogid B, Shorr AF, Stryjewski ME, Wang W
|
|
|
27.
|
|
|
|
28.
|
|
